Expression level of beta-catenin is associated with prognosis of esophageal carcinoma

Figure 1 Solution curve of beta-catenin gone PCR products (A and standard curve of beta-catenin gone PCR products (B).

Figure 2 A: ESCC patients at stages III- IV(A) showing higher mRNA expression level of beta-catenin than ESCC patients at stages I-II(B). Y: observed lymph node metastasis, N: no lymph node metastasis. ESCC patients with lymph node metastasis had higher mRNA expression level of beta-catenin than ESCC patients with no lymph node metastasis.

Figure 3 At the advanced stage (pT2-pT4), a significant difference in survival between patients at advanced stage with level 1 and 2 expression.